Annual Current Assets
$225.69 M
+$53.36 M+30.97%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual total current assets is $225.69 million, with the most recent change of +$53.36 million (+30.97%) on April 30, 2024.
- During the last 3 years, KALV annual current assets has fallen by -$38.57 million (-14.60%).
- KALV annual current assets is now -14.60% below its all-time high of $264.26 million, reached on April 30, 2021.
Performance
KALV Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$152.27 M
-$39.37 M-20.54%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly total current assets is $152.27 million, with the most recent change of -$39.37 million (-20.54%) on October 31, 2024.
- Over the past year, KALV quarterly current assets has dropped by -$73.42 million (-32.53%).
- KALV quarterly current assets is now -42.38% below its all-time high of $264.26 million, reached on April 30, 2021.
Performance
KALV Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
KALV Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +31.0% | -32.5% |
3 y3 years | -14.6% | -35.1% |
5 y5 years | +95.3% | +41.1% |
KALV Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -14.6% | +31.0% | -32.5% | +46.3% |
5 y | 5-year | -14.6% | +154.4% | -42.4% | +143.6% |
alltime | all time | -14.6% | +4820.2% | -42.4% | +3434.5% |
KalVista Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Oct 2024 | - | $152.27 M(-20.5%) |
Jul 2024 | - | $191.63 M(-15.1%) |
Apr 2024 | $9.71 M(-10.7%) | $225.69 M(+116.8%) |
Jan 2024 | - | $104.10 M(-19.1%) |
Oct 2023 | - | $128.61 M(-14.2%) |
Jul 2023 | - | $149.84 M(-13.0%) |
Apr 2023 | $10.88 M(+6.3%) | $172.33 M(-10.3%) |
Jan 2023 | - | $192.13 M(+27.1%) |
Oct 2022 | - | $151.22 M(-11.3%) |
Jul 2022 | - | $170.41 M(-12.0%) |
Apr 2022 | - | $193.65 M(-9.7%) |
Apr 2022 | $10.23 M(+32.1%) | - |
Jan 2022 | - | $214.46 M(-8.5%) |
Oct 2021 | - | $234.48 M(-6.1%) |
Jul 2021 | - | $249.78 M(-5.5%) |
Apr 2021 | $7.75 M(+102.2%) | $264.26 M(+322.8%) |
Jan 2021 | - | $62.50 M(-13.3%) |
Oct 2020 | - | $72.08 M(-10.2%) |
Jul 2020 | - | $80.22 M(-9.6%) |
Apr 2020 | $3.83 M | $88.70 M(-10.4%) |
Jan 2020 | - | $99.00 M(-8.2%) |
Oct 2019 | - | $107.89 M(-6.8%) |
Date | Annual | Quarterly |
---|---|---|
Jul 2019 | - | $115.72 M(+0.1%) |
Apr 2019 | $2.59 M(+28.7%) | $115.55 M(-6.9%) |
Jan 2019 | - | $124.06 M(-4.6%) |
Oct 2018 | - | $130.07 M(+135.7%) |
Jul 2018 | - | $55.19 M(-7.1%) |
Apr 2018 | $2.01 M(+1266.7%) | $59.38 M(-9.6%) |
Jan 2018 | - | $65.71 M(+92.5%) |
Oct 2017 | - | $34.14 M(+13.1%) |
Jul 2017 | - | $30.19 M(-11.7%) |
Apr 2017 | $147.00 K(+98.6%) | $34.20 M(-9.9%) |
Jan 2017 | - | $37.95 M(+6.0%) |
Sep 2016 | - | $35.81 M(-5.6%) |
Jun 2016 | - | $37.96 M(-23.3%) |
Apr 2016 | $74.00 K(-96.0%) | - |
Mar 2016 | - | $49.47 M(-10.0%) |
Dec 2015 | $1.85 M(-10.3%) | $54.95 M(-10.6%) |
Sep 2015 | - | $61.45 M(-8.3%) |
Jun 2015 | - | $67.00 M(+1455.1%) |
Mar 2015 | - | $4.31 M(-6.1%) |
Dec 2014 | $2.06 M(+954.9%) | $4.59 M(-51.7%) |
Sep 2014 | - | $9.49 M(-4.3%) |
Dec 2013 | $195.00 K(-4.4%) | $9.91 M |
Dec 2012 | $204.00 K | - |
FAQ
- What is KalVista Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual current assets year-on-year change?
- What is KalVista Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly current assets year-on-year change?
What is KalVista Pharmaceuticals annual total current assets?
The current annual current assets of KALV is $225.69 M
What is the all time high annual current assets for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual total current assets is $264.26 M
What is KalVista Pharmaceuticals annual current assets year-on-year change?
Over the past year, KALV annual total current assets has changed by +$53.36 M (+30.97%)
What is KalVista Pharmaceuticals quarterly total current assets?
The current quarterly current assets of KALV is $152.27 M
What is the all time high quarterly current assets for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly total current assets is $264.26 M
What is KalVista Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, KALV quarterly total current assets has changed by -$73.42 M (-32.53%)